How the type of risk reduction influences required sample sizes in randomised clinical trials.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 15231507.
- Also identified by PMC identifier 1754827.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To increase change between groups, randomised clinical trials (RCT) often include patients with high risk for a particular outcome, by inclusion criteria that select predictors for that outcome. This increases the statistical power, and fewer patients are required for that RCT. The way in which patient selection influences the power, and thus sample size required, depends on how an intervention reduces the individual risk: by an absolute or relative risk reduction model.
Medical subject headings
- Patient Selection
- Randomized Controlled Trials as Topic
- Rheumatology